Detalles de la búsqueda
1.
Factor XIII deficiency in two Spanish families with a novel variant in gene F13A1 detected by next-generation sequencing; symptoms and clinical management.
J Thromb Thrombolysis
; 50(3): 686-688, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32060721
2.
The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab.
Haemophilia
; 25(4): 676-684, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31033112
3.
Efficacy and safety evaluation of Fanhdi® , a plasma-derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study.
Haemophilia
; 28(1): e23-e27, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34735040
4.
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.
Blood
; 122(11): 1954-62, 2013 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23926300
5.
Predictive factors of immune tolerance treatment response in severe haemophilia A patients with inhibitors: A real-world report from a single centre, mixed retrospective-prospective long-term study.
Haemophilia
; 25(2): e97-e100, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30604912
6.
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate® ) and BAY 81-8973 (Kovaltry® ) in patients with severe or moderate haemophilia A in prophylaxis.
Haemophilia
; 25(3): e215-e218, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30866068
7.
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients.
Thromb Res
; 205: 99-105, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34293540
8.
Management of acquired hemophilia A: results from the Spanish registry.
Blood Adv
; 5(19): 3821-3829, 2021 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34521101
9.
Novel missense mutation c.2685G>C (p.Q895H) in VWF gene associated with very low levels of VWF mRNA.
Ann Hematol
; 88(3): 245-7, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18712522
10.
Prophylactic treatment in hemophilic patients with inhibitors.
Blood Coagul Fibrinolysis
; 30(1S Suppl 1): S14-S18, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31517711
11.
Severe and moderate hemophilia A: identification of 38 new genetic alterations.
Haematologica
; 93(7): 1091-4, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18403393
12.
Large deletion in the Factor VIII gene (F8) involving segmental duplications in int22h shows no haematological phenotype in female carriers, but may be embryonic lethal in males.
Br J Haematol
; 158(1): 138-40, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22429151
13.
Allogeneic hematopoietic cell transplantation in an adult patient with Glanzmann thrombasthenia.
Clin Case Rep
; 5(11): 1887-1890, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29152293
14.
Von Willebrand's disease: a novel mutation, P1824H and the incidence of R1205H defect among families with dominant quantitative von Willebrand factor deficiency.
Haematologica
; 91(8): 1130-3, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16870550
15.
Clinical and molecular characterization by next generation sequencing of Spanish patients affected by congenital deficiencies of fibrinogen.
Thromb Res
; 180: 115-117, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31295712
16.
Identification of deletion carriers in hemophilia B: quantitative real-time polymerase chain reaction or multiple ligation probe amplification.
Transl Res
; 153(3): 114-7, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19218093
17.
Molecular analyses in hemophilia B families: identification of six new mutations in the factor IX gene.
Haematologica
; 88(2): 235-6, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12604421
Resultados
1 -
17
de 17
1
Próxima >
>>